Felix Theeuwes
2009
In 2009, Felix Theeuwes earned a total compensation of $1.2M as Chairman and Chief Scientific Officer at DURECT, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $25,151 |
|---|---|
| Option Awards | $643,682 |
| Salary | $473,660 |
| Other | $11,641 |
| Total | $1,154,134 |
Theeuwes received $643.7K in option awards, accounting for 56% of the total pay in 2009.
Theeuwes also received $25.2K in non-equity incentive plan, $473.7K in salary and $11.6K in other compensation.
Rankings
In 2009, Felix Theeuwes' compensation ranked 3,968th out of 9,885 executives tracked by ExecPay. In other words, Theeuwes earned more than 59.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,968 out of 9,885 | 60th |
Division Manufacturing | 1,413 out of 3,690 | 62nd |
Major group Chemicals And Allied Products | 268 out of 866 | 69th |
Industry group Drugs | 156 out of 638 | 76th |
Industry Pharmaceutical Preparations | 123 out of 446 | 72nd |
Source: SEC filing on April 28, 2011.
Theeuwes' colleagues
We found four more compensation records of executives who worked with Felix Theeuwes at DURECT in 2009.